Announcement on Repurchasing 1% Shares through Call Auction and Progress in Repurchasing Shares
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Repurchasing 1% Shares through Call Auction and Progress in Repurchasing Shares
Filed with SSE · · 2 pages · Chinese
Release
Shanghai Medicilon, Inc. on 6ix
Earlier from Shanghai Medicilon
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Share Reduction Plan for Shareholder
- Announcement on Attending the Annual Collective Performance Briefing for Innovative Drug Industry on SSE STAR Market 2024 and Convening Q1 2025 Performance Briefing
- Announcement on Initially Repurchasing the Company's Shares through Call Auction
- Announcement on Provision for Asset Impairment and Write-off of Assets in 2024
Later from Shanghai Medicilon
- Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence
- Announcement on Equity Change of Shareholders Reaching 1% and Results of Shareholding Reduction
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Abnormal Fluctuations in Stock Trading
- Announcement on Implementation Results of Share Repurchase and Share Changes
Follow Shanghai Medicilon into a list and get an email when it puts out news.
Follow Shanghai Medicilon